5STOJANOV P, DJORDJEVIC M, VELIMIROVIC D, et al. Assessment of long term stability of chronic ventricular pacing thresholds in steroid-eluting electrodes [J]. PACE,1992,15:1417-1420.
6FURMAN S, BENEDEK Z M, ANDREWS C A, et al. Long-term follow-up of pacemaker lead systems: establishment of standards of quality [J]. PACE, 1995,18:271-285.
7Rishi F, Hulse JE , Auld Do , et al. Effects of dual-chamber pacing for Pediatric Patients with Hypertrophic obstructire cardiomyopathy. J Am Coll Cardiol,1977,29 : 734.
8Gras D, Mabo P, Deplace C, et al . Outcome of mitral regurgitation in obstructive hypertrophic cardiomyopathy treated by DDD. Pacing [abstract] Circulaion,1944, 90(suppl): 1-443.
9Jeanreaud X, Coy J-J, Kappenberger L. Effects of duel chamber pacing in hypertrophic obstructive cardiomyopathy. Lancet, 1922,339:1 381-1 323.
10Fananapazir, Epstein No, Curiel Rv, et al. Long term results of dualchamber (DDD) pacing in obstructive hgper-trophic cardiomyopathy: evidence for progressive symptomatic and hemodynamic improvement and reduction of lefe ventricular hypertrophy. Circulation, 1994,90:2 731-2 742.
1Morgan LB, Hartzell VS,Joseph AD,et al. Relationship between left ventricular mass, wall thickness, and survival after subaortic septal myectomy for hypertrophic obstructive cardiomyopathy [ J ]. J Thor Cardiov Surg,201 l, 141 (2) :439 - 443.
2Raphael P,Jacques Q ,Thomas C, et al. Delayed occurrence of com- plete heart block after ethanol septal ablation for hypertrophic ob- structive cardiomyopathy [ J ]. Inter J Cardiol, 2011 , 147 ( 2 ) : 32 - 34.
3Sherif FN,Bertron MG,Leonard S,et al. Alcohol septal ablation for the treatment of hypertrophic obstructive cardiomyopathy: A Mohi- center North American Registry[J]. J Am College Cardiol,2011,58 (22) :2322 -2328.
